Lead Product(s) : Ibandronate Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Taisho Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Transfer and Future Marketing of Osteoporosis Agent Bonviva in Japan
Details : Bonviva is a medicine that contains the active substance ibandronic acid. It is available as tablets (150 mg) and as a solution for injection in a prefilled syringe (3 mg).
Product Name : Bonviva
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 24, 2022
Lead Product(s) : Ibandronate Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Taisho Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
